| Moderator 主持人 | Weifeng Shen 沈卫峰, Xiangjun Yang 杨向军, Yining Yang 杨毅宁, Xiang Song 宋湘 | |
|
1:30 PM- |
Long-Term Outcomes after Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary Syndrome (AS-0010) 急性冠脉综合征患者左主干PCI术后长期临床结局的研究（AS-0010） |
Sida Jia 贾斯达 |
|
1:40 PM- |
Q&A 讨论 |
|
|
1:45 PM- |
In-Hospital Outcomes of Delayed Stenting in Patients with ST-Segment Elevation Myocardial Infarction: Findings from the Improving CCC Project (Care for Cardiovascular Disease in China) (AS-0028) 急性ST段抬高型心肌梗死患者延迟PCI的住院期间疗效观察（CCC-中国心血管医疗质量改善项目）（AS-0028） |
Jiawei Wu 吴佳纬 |
|
1:55 PM- |
Q&A 讨论 |
|
|
2:00 PM- |
Efficiency and Safety of Bivalirudin in Elderly Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (AS-0032) 高龄急性心肌梗死患者直接经皮冠状动脉介入治疗围术期应用比伐芦定的疗效与安全性（AS-0032） |
Xiaofan Yu 余晓凡 |
|
2:10 PM- |
Q&A 讨论 |
|
|
2:15 PM- |
Is the SYNTAX Score II Suitable to Extend to All Percutaneous Coronary Intervention Patients? (AS-0035) SYNTAX评分II的预后预测能力是否适合扩展到所有PCI患者（AS-0035） |
Guofeng Gao 高国峰 |
|
2:25 PM- |
Q&A 讨论 |
|
|
2:30 PM- |
Efficacy and Safety of Drug-Eluting Balloons for In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials (AS-0038) 药物洗脱球囊治疗支架内再狭窄的疗效和安全性：一项随机对照试验的荟萃分析（AS-0038） |
Yue Wang 王悦 |
|
2:40 PM- |
Q&A 讨论 |
|
|
2:45 PM- |
Physiological Serum Concentration of Gamma-Glutamyl Transferase Reversely Associated with Long-Term Mortality in Coronary Artery Disease after Percutaneous Coronary Intervention: Results from a 10-Year Follow-up of CORFCHD-PCI Study (AS-0041) 生理水平的转肽酶和冠心病患者PCI术后不良结局呈负相关（AS-0041） |
Yingying Zheng 郑颖颖 |
|
2:55 PM- |
Q&A 讨论 |
|
|
3:00 PM- |
Long-Term Dual Antiplatelet Therapy Increased Adverse Events after PCI (AS-0043) PCI术后长期双抗治疗增加不良事件发生率（AS-0043） |
Xiang Xie 谢翔 |
|
3:10 PM- |
Q&A 讨论 |
|
|
3:15 PM- |
Adjourn 休会 |
|